1. Home
  2. AMPG vs MREO Comparison

AMPG vs MREO Comparison

Compare AMPG & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitech Group Inc.

AMPG

Amplitech Group Inc.

HOLD

Current Price

$4.99

Market Cap

51.7M

ML Signal

HOLD

Logo Mereo BioPharma Group plc

MREO

Mereo BioPharma Group plc

HOLD

Current Price

$0.28

Market Cap

52.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMPG
MREO
Founded
2002
2015
Country
United States
United Kingdom
Employees
47
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.7M
52.5M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AMPG
MREO
Price
$4.99
$0.28
Analyst Decision
Strong Buy
Buy
Analyst Count
1
5
Target Price
$7.00
$1.50
AVG Volume (30 Days)
2.9M
1.8M
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.67
EPS
N/A
N/A
Revenue
N/A
$500,000.00
Revenue This Year
$102.41
$5,184.20
Revenue Next Year
$20.00
$55.51
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.64
$0.20
52 Week High
$5.60
$2.94

Technical Indicators

Market Signals
Indicator
AMPG
MREO
Relative Strength Index (RSI) 81.83 49.24
Support Level $2.73 $0.21
Resistance Level N/A $0.36
Average True Range (ATR) 0.50 0.03
MACD 0.31 0.01
Stochastic Oscillator 82.49 55.27

Price Performance

Historical Comparison
AMPG
MREO

About AMPG Amplitech Group Inc.

AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. It operates in two segments: the manufacturing and engineering segment. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.

About MREO Mereo BioPharma Group plc

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat, mainly for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Share on Social Networks: